Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 3Other hematologic neoplasm 1Endocrine 1Breast 1

Conditions

Neoplasms 3

Interventions

pembrolizumab 94Paclitaxel 85Gemcitabine 83Carboplatin 79Docetaxel 60Cisplatin 58Bevacizumab 58Nivolumab 56Fluorouracil 47Capecitabine 46Magnetic Resonance Spectroscopy 44Radiotherapy 41Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 37Pemetrexed 34Leucovorin 34Biopsy 34atezolizumab 33Cetuximab 32Standard of Care 31Trastuzumab 28Cyclophosphamide 28Radiosurgery 27Blood Specimen Collection 27Specimen Handling 26Sorafenib 26Ipilimumab 26Everolimus 26olaparib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Health × Tumor-Agnostic × Clear all
NCT06058312 2026-04-30

MyPrefMed

Centre Antoine Lacassagne

Phase NA Completed
116 enrolled
Tumor-Agnostic

Neoplasms

NCT03979794 2024-11-14

A Distress Screening and Intervention in Cancer Surgery

Baylor College of Medicine

Phase NA Terminated
16 enrolled
Tumor-Agnostic

Neoplasms

NCT03446092 2022-05-12

Mindfulness for People With Incurable Cancer

Lancaster University

Phase NA Completed
3 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡